Sollis lands $50m for long-acting pain-relief drug

Sollis Therapeutics closed a $50 million round to support a pivotal trial of its non-opioid pain-reliever, according to Ohio-based translator NeuroTechnology Innovations Translator. Deerfield Management led the funding round and was joined by NIT collaborators, including Medtronic (NYSE:MDT), Cardinal Health and Ohio State University. Get the full story at our sister site, Drug Delivery Business News. The post Sollis lands $50m for long-acting pain-relief drug appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Funding Roundup Pain Management Pharmaceuticals sollistherapeutics Source Type: news